# Sublingual Immunotherapy of Birch Pollen Associated Apple Allergy

> **NCT01449786** · PHASE2 · COMPLETED · sponsor: **Medical University of Vienna** · enrollment: 60 (actual)

## Conditions studied

- Birch Pollen Related Apple Allergy
- Birch Pollen Allergy

## Interventions

- **DRUG:** rMal d 1
- **DRUG:** rBet v 1
- **OTHER:** placebo drops

## Key facts

- **NCT ID:** NCT01449786
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03-14
- **Primary completion:** 2014-02-28
- **Final completion:** 2016-12-20
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2017-04-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01449786

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01449786, "Sublingual Immunotherapy of Birch Pollen Associated Apple Allergy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01449786. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*